The effects of adjuvant Tualang honey therapy on disease activity markers in systemic lupus erythematosus patients
Not Applicable
Completed
- Conditions
- systemic lupus erythematosusAlternative and Complementary Medicine - Other alternative and complementary medicineInflammatory and Immune System - Autoimmune diseases
- Registration Number
- ACTRN12611000074998
- Lead Sponsor
- School of Medical Sciences, Universiti Sains Malaysia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
SLE patients fulfilled 4 out of 11 ARA criteria
on low dose prednisolone alone or combination with other immunosuppressive drugs and / or either cyclophosphomide or azathioprine maintenance treatment
Exclusion Criteria
patients who were diabetic, pregnant, suffering from chronic renal failure, cancer, HIV and allergic to honey
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction of SLEDAI score in the honey group compared to non honey group[6 months];increase in complement level ( enzyme cascade to prevent infection ) in the honey group compared to non honey group.<br>Complement level is measured by peripheral blood[6 months]
- Secondary Outcome Measures
Name Time Method nil[nil]